Lead sponsor
BeyondBio Inc.
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
1
Ongoing
178
Total enrollment
4
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
1
Trials by status
Not yet recruiting
1
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's DiseaseAlzheimer's diseasePh 2Not yet recruiting90
A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy ParticipantsAge 19-80Ph 1Completed88